Post Categories
Blog post not found!
New Draft FDA Guidance on ADC Pharmacology
March 23, 2022
The market for antibody-drug conjugates, or ADCs, is hotter than ever before. In response, the Food and Drug Administration (FDA) released new guidance on clinical…
Lilly/Entos Deal Reinforces the Significance of Delivery Mechanisms for Nucleic Acid-Based Therapies
March 21, 2022
As part of a research partnership aimed at improving the delivery of nucleic acid-based therapies targeting nervous system diseases, American pharmaceutical company Eli Lilly…
Gene Deserts May Hold an Oasis — a Cure for HIV
March 14, 2022
In human cells infected by the human immunodeficiency virus (HIV), virus particles can leave behind part of their genetic material, which gets incorporated into…
New AstraZeneca Drug for HER2-Low Breast Cancer Aces Phase III Trial
March 9, 2022
Infographics Not all cancer cases are created equal. As the medical community hones in on better, less invasive cancer treatments, differentiating between different types…
Superbugs Emerging as Super-Big Problem, Demand Urgent Attention
March 7, 2022
Results of a comprehensive global study of antimicrobial resistance (AMR) show that infections caused by antibiotic-resistant bacteria — also known as “superbugs” — were…
Longhorn Beetles, 200-Year-Old Fish, and How Genetics Drive Genomic Diversity
March 2, 2022
The sternotomis callais beetle, otherwise known as the flat-faced longhorn beetle, resides in Central Africa. Rockfish, a species of fish known for their long…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…